Investigation of Locus Coeruleus Function in Sustained Attention

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-60
SponsorUniversity of California, Davis

About this trial

The norepinephrine-producing locus coeruleus (LC) is thought to be central to a wide array of cognitive functions, like attention and goal pursuit, and has been implicated in dysfunctions including attention deficit hyperactivity disorder and schizophrenia. The goal of this proposal is to develop methods that permit measurement of activity in the human LC. Because the LC is small and located in the pons, the Investigators will use high resolution magnetic resonance imaging techniques tailored to the brainstem environment, including neuromelanin-sensitive images shown to delineate the LC, combined with pharmacological manipulation to confirm the location of functional activity.

Eligibility criteria

Qualifiers

Between the ages of 18 - 60 years of age,

Typically developing, healthy adult

Disqualifiers

History of schizophrenia, other forms of psychosis,

Specific or focal neurological disorder or severe alcohol or drug use disorder within the past 5 years

History of left ventricular hypertrophy or in patients with mitral valve prolapse who have experienced the mitral valve prolapse syndrome when previously receiving CNS stimulants, or who have had recent history of myocardial infarction or unstable angina.

Volunteers with known hypersensitivity to modafinil or armodafinil or its inactive ingredients

Trial design

Treatments tested in this trial

  • Modafinil

Treatment groups

40 Participants
are divided into 2 treatment groups